5-Amino-1MQ Chemistry: A Small-Molecule Reference Sheet
A bench-level reference on 5-Amino-1MQ, the non-peptide small-molecule NNMT inhibitor built on a quinolinium scaffold: how it is structured, how it is made, how its identity is confirmed, and how it is kept as a research reference standard.
Structure of the Quinolinium Scaffold
5-Amino-1MQ is a non-peptide small molecule, not a peptide, so it has no amino-acid sequence and no residues to read off. Its structure is a single quinolinium scaffold: a bicyclic quinoline ring system whose ring nitrogen is methylated, which gives the molecule a fixed positive charge and makes it a quaternary aromatic salt. An amino group sits on the ring as the defining substituent, and that compact, planar architecture is the first thing to read off the molecule because it governs how it behaves through synthesis, on the column, and in storage.
Because the molecule is a defined small structure rather than a chain, there is no folding, no disulfide chemistry, and no sequence-level quality concern to manage. A research chemist treats 5-Amino-1MQ as a single, well defined structure whose properties, including its solubility as a charged salt and its chromatographic retention, follow directly from that ring system and its substituents. Reading the structure first is the same discipline applied across the research overviews, where the identity and composition of a molecule set expectations before any material is handled.
Where It Sits: an NNMT Inhibitor
The defining functional fact about 5-Amino-1MQ is that it is studied as an inhibitor of nicotinamide N-methyltransferase, or NNMT, the enzyme that methylates nicotinamide. As a small-molecule inhibitor rather than a hormone analog or a protein fragment, it sits apart from the peptide families in the catalog. It is a designed or selected small structure whose interest comes from how the molecule engages that enzyme, not from any sequence ancestry.
That placement matters for how it is grouped and studied. In the BioFusion catalog 5-Amino-1MQ is filed with the mitochondrial compounds alongside other non-peptide research molecules such as SLU-PP-332, and it is approached as a small organic structure rather than as a residue-built peptide. Knowing a molecule is a small-molecule enzyme inhibitor frames the chemistry sensibly: the work is about preparing a single defined structure cleanly and confirming it, not about reproducing a sequence.
Synthesis by a Small-Molecule Route
Research-grade 5-Amino-1MQ is produced by a small-molecule synthetic route rather than by solid-phase peptide synthesis, because it is not a peptide and there are no residues to couple. The work centers on the quinoline ring: building or sourcing the quinoline core, installing the amino substituent at the appropriate position, and N-methylating the ring nitrogen to form the quinolinium salt. The product is then isolated and purified as a defined small-organic compound.
Because the target is a single molecule rather than a stepwise chain, the variables that shape the outcome are reaction selectivity and clean purification rather than coupling efficiency across many cycles. This is a different discipline from the Fmoc peptide overviews in the library, and it is one reason 5-Amino-1MQ groups naturally with the other non-peptide mitochondrial compounds: they share a small-molecule preparation and the analytical methods that go with it.
How Identity and Purity Are Confirmed
Identity and purity for 5-Amino-1MQ are established with the same two complementary methods used across the reference catalog. Reversed-phase HPLC separates the target compound from related synthetic impurities and reports purity as the share of the total peak area attributable to the intended molecule. Mass spectrometry confirms identity by matching the measured mass to the value expected for the quinolinium structure.
These two read together. The HPLC profile describes how much of the sample is the intended compound relative to other UV-absorbing species, while the mass result confirms that the main peak is the right molecule and not a same-mass impurity. Both are descriptions of the chemistry of a single defined structure, and the right way to read them is together rather than in isolation. The general approach to identity and purity work is covered further in the standards and verification overview.
Stability and Storage
As a dry solid, 5-Amino-1MQ is comparatively stable when kept cool, dry, and out of light. Long-term storage of the dry material is best with the container protected from moisture so the salt does not pick up water on opening, and letting a sealed container reach room temperature before it is opened helps avoid condensation forming on the cold contents. As a charged quinolinium salt it is generally water-soluble, which is worth keeping in mind when planning handling.
Once in solution, the working preparation is less forgiving. Small molecules in solution can be subject to hydrolysis, oxidation, and light sensitivity, so a prepared solution is generally held cold, protected from light, and used within a short window. These are general handling principles for research compounds rather than claims about any one preparation, and the documentation for a given standard should be the reference of record for its own conditions.
What 5-Amino-1MQ Is Studied For (Chemistry Only)
In a research-chemistry context, 5-Amino-1MQ is of interest as a compact, well defined small-molecule enzyme inhibitor and as a model system for non-peptide NNMT-directed chemistry. It is studied in laboratory metabolic and mitochondrial research as a chemistry subject, where the questions are about how the quinolinium structure is synthesized, how its identity and purity are confirmed, and how it behaves under handling and storage. Its single defined structure makes it a useful reference point when validating synthesis and analytical methods on related small molecules.
That framing is deliberately limited to the bench. 5-Amino-1MQ reference material is for laboratory research only, and nothing here describes or implies any human or veterinary use or outcome. Its value to a research chemist is as a chemistry subject: a defined small-molecule structure whose synthesis, characterization, and storage behavior are well understood and worth knowing in detail.
This overview is provided for laboratory and research use only. It is educational chemistry reference material and is not for human or veterinary consumption. Buyers are responsible for compliance with all applicable laws and regulations.
Common questions
Q.What is 5-Amino-1MQ?
5-Amino-1MQ is a non-peptide small molecule built on a quinolinium scaffold, an aromatic ring system carrying a fixed positive charge, an amino substituent, and an N-methyl group. It is studied in research chemistry as an NNMT inhibitor and is handled as a laboratory reference standard. It is research use only and not for human or veterinary use.
Q.Is 5-Amino-1MQ a peptide?
No. 5-Amino-1MQ is not a peptide and has no amino-acid sequence or residues. It is a defined small molecule with a single quinolinium ring structure, so it is read as a structure rather than as a chain of residues. That distinction shapes how it is synthesized, characterized, and stored compared with the peptide standards in the catalog.
Q.How is 5-Amino-1MQ synthesized?
Research-grade 5-Amino-1MQ is made by a small-molecule synthetic route rather than by solid-phase peptide synthesis. The work centers on building or functionalizing the quinoline ring, installing the amino substituent, and N-methylating the ring nitrogen to give the quinolinium salt, followed by purification. It is a small-organic preparation, not a stepwise residue assembly.
Q.How should 5-Amino-1MQ reference material be stored?
As a dry solid, 5-Amino-1MQ is best kept cool, dry, and out of light, with the container protected from moisture so the salt does not pick up water on opening. Letting a sealed container reach room temperature before opening helps avoid condensation. Solutions are less stable and are generally held cold, protected from light, and used within a short window.